Study Guide: Pharmacology | 4S | Before Class

Student purpose

This guide focuses on recognizing medication-related patterns, differentiating similar adverse reactions, identifying dangerous complications, prioritizing nursing actions, and evaluating outcomes.

Clinical Topics

1. Antiepileptics: Acute Toxicity vs. Chronic Adverse Effects

Antiepileptic medications require careful assessment because toxicity, chronic adverse effects, and serious idiosyncratic reactions may look very different.

Phenytoin

Acute toxicity pattern

Nystagmus, ataxia, diplopia, slurred speech, and impaired coordination are important neurologic clues associated with elevated phenytoin levels.

Chronic effects

Gingival hyperplasia and hirsutism are associated with long-term therapy, but they do not independently indicate acute toxicity.

Clinical reasoning When the serum concentration is elevated, prioritize NEW neurologic findings over chronic cosmetic effects that may have been present for months.

Other high-yield antiepileptics

Medication	Major safety concept
Carbamazepine	Bone marrow suppression, hyponatremia, serious skin reactions
Valproate	Hepatotoxicity, pancreatitis, thrombocytopenia, teratogenic risk
Lamotrigine	New rash can signal a serious cutaneous reaction and requires prompt evaluation
Levetiracetam	Monitor for behavioral and mood changes

NCLEX Pearl Do not automatically classify every known adverse effect as evidence of acute toxicity. Timing and change from baseline matter.

2. Reproductive Medications: Thromboembolism and Cardiovascular Safety

Estrogen-containing contraceptives increase thromboembolic risk. The nurse must recognize when a common complaint becomes a potential vascular emergency.

DVT pattern

New unilateral swelling, warmth, tenderness, or calf pain should raise concern for deep vein thrombosis.

Risk increases when combined

Estrogen exposure, smoking, and prolonged immobility can compound thromboembolic risk.

Safety Do not massage an extremity when DVT is suspected. Prompt evaluation is more important than treating the leg discomfort.

Sildenafil + nitrates

Sildenafil and nitrates can produce dangerous additive vasodilation and severe hypotension. Medication reconciliation is therefore essential before administering nitrates to a client who may use a PDE-5 inhibitor.

Think combinations Many pharmacology emergencies occur because two individually familiar medications become dangerous when combined.

3. GI Medications: Neurologic vs. Cardiac Adverse Effects

Antiemetics may be prescribed for the same symptom but have very different mechanisms and safety profiles.

Medication	Important adverse effect	Clinical clue
Metoclopramide	Extrapyramidal symptoms / acute dystonia	Neck spasm, torticollis, abnormal eye movements, oculogyric crisis
Ondansetron	QT prolongation	Increasing QTc, especially with hypokalemia or another QT-prolonging drug

Mechanism matters Metoclopramide’s dopamine-blocking activity explains its EPS risk. Ondansetron requires a different safety assessment because its major high-risk complication is cardiac electrical instability.

Avoid pattern matching by indication Two drugs used for nausea are not pharmacologically interchangeable. Always ask which adverse effect belongs to which mechanism.

4. Antipsychotics: EPS, Tardive Dyskinesia, and NMS

Dopamine-blocking antipsychotics can cause several neurologic adverse reactions. Timing and symptom pattern help distinguish them.

Problem	Typical pattern	Priority concept
Acute dystonia	Muscle spasms, torticollis, oculogyric crisis	Acute EPS requiring treatment
Akathisia	Restlessness, inability to remain still	Differentiate from psychiatric agitation
Tardive dyskinesia	Involuntary repetitive movements, often oral/facial	Associated with longer-term dopamine blockade
NMS	High fever, severe lead-pipe rigidity, altered mental status, autonomic instability	Life-threatening emergency

NMS emergency pattern Hyperthermia + severe generalized rigidity + altered mental status + autonomic instability after antipsychotic exposure should trigger immediate concern for neuroleptic malignant syndrome.

Why CK matters Severe sustained muscle rigidity can cause rhabdomyolysis. Creatine kinase may rise substantially, increasing concern for renal injury.

5. Methotrexate and DMARD Safety: When a Dosing Error Becomes Toxicity

Low-dose methotrexate used for inflammatory disorders is commonly prescribed on a weekly schedule. Medication-frequency errors can result in severe toxicity.

Mucositis

New painful mouth ulcers can be an important toxicity cue, especially when accompanied by systemic abnormalities.

Bone marrow suppression

Leukopenia, neutropenia, anemia, or thrombocytopenia may develop with significant toxicity.

Hepatotoxicity

Elevated liver enzymes provide another clue that toxicity may involve multiple organ systems.

High-risk medication error Confusing a weekly methotrexate regimen with daily administration can cause serious and potentially life-threatening toxicity.

Folic acid vs. leucovorin Routine folic acid supplementation can reduce some adverse effects during appropriate therapy. Leucovorin (folinic acid) has a distinct role as rescue therapy in significant methotrexate toxicity.

6. Antidepressants: Serotonin Syndrome and High-Risk Interactions

Serotonin syndrome results from excessive serotonergic activity, often after adding or combining serotonergic medications.

Mental status

Agitation, confusion, or altered behavior may occur.

Autonomic findings

Hyperthermia, tachycardia, hypertension, and diaphoresis may be present.

Neuromuscular findings

Hyperreflexia, tremor, and especially clonus strongly support serotonin toxicity.

Medication combinations matter A newly added serotonergic medication can convert a previously tolerated regimen into a dangerous interaction.

Other antidepressant safety concepts

SSRIs/SNRIs: monitor for serotonin toxicity and clinically significant mood or behavioral changes.
TCAs: overdose can produce dangerous cardiac and anticholinergic toxicity.
MAOIs: dangerous interactions can occur with tyramine-rich foods and certain medications.

NCLEX Pearl In a febrile patient taking psychiatric medications, the neuromuscular examination may provide the clue that separates serotonin syndrome from NMS.

7. Chemotherapy: Neutropenia, Infection, Bleeding, and Myelosuppression

Chemotherapy can suppress bone marrow production. The CBC must be interpreted according to which cell line is affected.

Finding	Main clinical risk
Low neutrophils / low ANC	Infection
Low platelets	Bleeding
Low hemoglobin	Anemia, fatigue, reduced oxygen-carrying capacity

Neutropenic fever Fever in a severely neutropenic client is a medical emergency. Do not wait for dramatic localizing signs of infection before escalating care.

Priority response Prompt notification, infection-prevention measures, cultures as ordered, and timely antimicrobial therapy are central priorities.

Supportive hematologic medications

Agents such as filgrastim may be used to stimulate neutrophil production in selected patients. Epoetin stimulates erythropoiesis and addresses a different cell-line problem.

Do not over-select An abnormal CBC does not mean every hematologic risk is present. Identify which cell line is actually compromised.

8. Sedative-Hypnotics: Intoxication vs. Withdrawal

The same medication class can create completely different emergencies depending on whether the patient has taken too much or abruptly stopped chronic use.

CNS depression

Sedation, decreased level of consciousness, impaired coordination, and respiratory compromise become especially dangerous when sedatives are combined with alcohol or other CNS depressants.

Withdrawal

Abrupt withdrawal after significant chronic exposure can produce anxiety, tremor, autonomic hyperactivity, hallucinations, and seizures.

Flumazenil is not automatically safe Although flumazenil antagonizes benzodiazepine effects, it can precipitate severe withdrawal and seizures in benzodiazepine-dependent patients. The clinical context matters.

Alcohol withdrawal Severe alcohol withdrawal can include hallucinations, marked autonomic hyperactivity, seizures, and delirium. Benzodiazepines are central to treatment according to the prescribed withdrawal protocol.

NCLEX Pearl Before choosing an antidote, ask: Is this intoxication—or is this withdrawal?

9. Integumentary Medications: Isotretinoin and High-Risk Safety Teaching

Isotretinoin is highly teratogenic. Prevention of fetal exposure is a central medication-safety priority.

Before therapy

Pregnancy status must be appropriately assessed before treatment begins.

During therapy

Required pregnancy-prevention measures and pregnancy surveillance must be maintained according to the applicable risk-management program.

Additional monitoring

Lipid and hepatic monitoring may be clinically important during therapy.

Teratogenicity Isotretinoin does not prevent pregnancy. Fetal exposure can cause severe birth defects.

Read the stem carefully A question may ask specifically about preventing pregnancy rather than general medication monitoring. A true statement about liver or lipid monitoring may still be the wrong answer to that specific question.

NCLEX Pearl Correct information is not automatically the correct answer. The answer must address exactly what the question is asking.

10. OTC and Toxidromes: Anticholinergic vs. Serotonergic vs. NMS

Over-the-counter medications are still pharmacologically active. Antihistamines such as diphenhydramine can produce clinically significant anticholinergic toxicity when taken in excessive amounts.

Pattern	High-yield findings	Key discriminator
Anticholinergic toxicity	Agitation, hyperthermia, tachycardia, dilated pupils, urinary retention, dry mucous membranes	DRY skin
Serotonin syndrome	Agitation, hyperthermia, autonomic activation, tremor, hyperreflexia, clonus	Clonus + hyperreflexia + diaphoresis
Neuroleptic malignant syndrome	High fever, altered mental status, autonomic instability, severe generalized rigidity	Lead-pipe rigidity

Wet vs. dry Serotonin syndrome commonly produces diaphoresis. Anticholinergic toxicity characteristically produces dry skin and dry mucous membranes.

Timing helps Serotonin syndrome often develops relatively rapidly after serotonergic exposure or interaction. NMS generally develops over a longer interval after dopamine-blocking medication exposure or dose escalation.

Clinical discrimination Do not stop at “fever + altered mental status.” Examine the skin, pupils, reflexes, muscle tone, medication history, and timing of symptom onset.

High-Yield Differentiation Table

Emergency Pattern	Medication Clue	Neuromuscular / Physical Clue	High-Yield Priority
Serotonin Syndrome	Serotonergic medications or interaction	Clonus, hyperreflexia, tremor, diaphoresis	Recognize rapidly and stop the offending serotonergic exposure as appropriate
NMS	Dopamine-blocking antipsychotic	Severe lead-pipe rigidity	Stop the offending antipsychotic and initiate urgent supportive management
Anticholinergic Toxicity	Antihistamine or other anticholinergic exposure	Dry skin, dilated pupils, urinary retention	Recognize the toxidrome and provide appropriate supportive/toxicologic management
Acute Dystonia	Dopamine-blocking medication	Neck spasm, torticollis, oculogyric crisis	Recognize as EPS rather than NMS
Severe Withdrawal	Abrupt cessation after chronic alcohol/sedative exposure	Tremor, autonomic hyperactivity, hallucinations, seizures	Prevent complications and treat according to withdrawal protocol

NGN Pharmacology Clinical Judgment Strategy

1. Identify the medication

Determine the medication class, recent additions, dose changes, long-term exposure, OTC use, and possible interactions.

2. Find the NEW cues

New neurologic findings, fever, abnormal movements, laboratory trends, unilateral symptoms, or changes in consciousness often carry more weight than stable chronic findings.

3. Build the pattern

Do not diagnose from one symptom. Combine medication history + timing + assessment + laboratory data.

4. Differentiate the look-alikes

Ask what finding should be present if your hypothesis is correct and what finding would point toward a competing diagnosis.

5. Identify the immediate threat

Prioritize hyperthermia, seizures, severe infection, thromboembolism, dangerous dysrhythmia risk, CNS depression, and organ toxicity.

6. Evaluate the response

Determine which measurable outcome would demonstrate improvement: temperature, mental status, muscle findings, CBC, ECG, symptoms, seizure activity, or another patient-specific parameter.

The Pharmacology II Question Behind the Question What medication or interaction is involved → what pattern does it create → what competing condition looks similar → which cue separates them → what threatens the patient most → what action addresses that threat?